These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2849673)

  • 1. Comparative pharmacology of endothelium-derived relaxing factor and nitric oxide.
    Shikano K; Long CJ; Ohlstein EH; Berkowitz BA
    J Pharmacol Exp Ther; 1988 Dec; 247(3):873-81. PubMed ID: 2849673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two types of relaxation responses mediated by cyclic GMP in cerebral arteries].
    Kanamaru K; Waga S; Kojima T; Fujimoto K
    No To Shinkei; 1989 Jun; 41(6):559-65. PubMed ID: 2553081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase.
    Mülsch A; Busse R; Liebau S; Förstermann U
    J Pharmacol Exp Ther; 1988 Oct; 247(1):283-8. PubMed ID: 2902213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA; Stewart DJ; Guérard MJ
    Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor.
    Martin W; Furchgott RF; Villani GM; Jothianandan D
    J Pharmacol Exp Ther; 1986 May; 237(2):529-38. PubMed ID: 3009791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.
    Martin W; Villani GM; Jothianandan D; Furchgott RF
    J Pharmacol Exp Ther; 1985 Mar; 232(3):708-16. PubMed ID: 2983068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase inhibitors induce endothelium-dependent relaxation of rat and rabbit aorta by potentiating the effects of spontaneously released endothelium-derived relaxing factor.
    Martin W; Furchgott RF; Villani GM; Jothianandan D
    J Pharmacol Exp Ther; 1986 May; 237(2):539-47. PubMed ID: 2422344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular reactivity to endothelium-derived relaxing factor in human umbilical artery at term pregnancy.
    Sugawara M; Tohse N; Nagashima M; Yabu H; Kudo R
    Can J Physiol Pharmacol; 1997 Jul; 75(7):818-24. PubMed ID: 9315349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NO/PGI2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery.
    Dong H; Waldron GJ; Galipeau D; Cole WC; Triggle CR
    Br J Pharmacol; 1997 Feb; 120(4):695-701. PubMed ID: 9051310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
    Jia L; Furchgott RF
    J Pharmacol Exp Ther; 1993 Oct; 267(1):371-8. PubMed ID: 8229764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.
    Buga GM; Gold ME; Wood KS; Chaudhuri G; Ignarro LJ
    Eur J Pharmacol; 1989 Feb; 161(1):61-72. PubMed ID: 2542037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
    Bassenge E; Busse R; Pohl U
    Circ Res; 1987 Nov; 61(5 Pt 2):II68-73. PubMed ID: 3117407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of doxazosin on the activity of the endothelium-derived relaxing factor.
    Yeates RA
    Arzneimittelforschung; 1994 Oct; 44(10):1117-21. PubMed ID: 7818583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
    Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
    Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of some products of protein catabolism on the endothelium-dependent and -independent relaxation of rabbit thoracic aorta rings.
    Sorrentino R; Sorrentino L; Pinto A
    J Pharmacol Exp Ther; 1993 Aug; 266(2):626-33. PubMed ID: 8355196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
    Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
    Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.